Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas

Oncogene

Volumn 21, Issue 43, 2002, Pages 6641-6648

  Xia, Shu Hua ^a   Hu, Li Ping ^b   Hu, Hai ^a   Ying, Wan Tao ^c   Xu, Xin ^a   Cai, Yan ^a   Han, Ya Ling ^a   Chen, Bao Sheng ^a   Wei, Fang ^a   Qian, Xiao Hong ^c   Cai, You Yu ^a   Shen, Yan ^b   Wu, Min ^a   Wang, Ming Rong ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c National Center of Biomedical Assay   (China)

Author keywords

Annexin I; Down regulated protein; Esophageal squamous cell carcinoma

Indexed keywords

ANNEXIN; ISOPROTEIN; MESSENGER RNA;

ARTICLE; BASAL CELL; CARCINOGENESIS; CONTROLLED STUDY; DISSECTION; DOWN REGULATION; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TWO DIMENSIONAL ELECTROPHORESIS;

ANNEXIN A1; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 18644379106     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205818     Document Type: Article

References (21)

1. Ahn SH, Sawada H, Ro JY and Nicolson GL. (1997). Clin. Exp. Metastasis, 15, 151-156.
2. Beranova-Giorgianni S and Desiderio DM. (2000). Rapid. Commun. Mass Spectrom., 14, 161-167.
3. Canaider S, Solito E, de Coupade C, Flower RJ, Russo-Marie F, Goulding NJ and Perretti M. (2000). Life Sci., 66, 265-270.
4. Chang MC, Chang YT, Wu MS, Shun CT, Tien YW and Lin JT. (2001). J. Formos. Med. Assoc., 100, 352-354.
5. Crompton MR, Moss SE and Crumpton MJ. (1988). Cell, 55, 1-3.
6. de Coupade C, Gillet R, Bennoun M, Bennoun M, Briand P, Russo-Marie F and Solito E. (2000). Hepatology, 31, 371-380.
7. Emmert-Buck MR, Gillespie JW, Paweletz CP, Ornstein DK, Basrur V, Appella E, Wang QH, Huang J, Hu N, Taylor P and Petricoin III EF. (2000). Mol. Carcinog., 27, 158-165.
8. Koseki H, Shiiba K, Suzuki Y, Asanuma T and Matsuno S. (1997). Surg. Today, 27, 30-39.
9. Lam AK. (2000). Crit. Rev. Oncol. Hematol., 33, 71-90.
10. Ornstein DK, Gillespie JW, Paweletz CP, Duray PH, Herring J, Vocke CD, Topalian SL, Bostwick DG, Linehan WM, Petricoin III EF and Emmert-Buck MR. (2000). Electrophoresis, 21, 2235-2242.
11. Ou K, Seow TK, Liang RC, Ong SE and Chung MC. (2000). Electrophoresis, 21, 2804-2811.
12. Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH, Herring J, Wang QH, Hu N, Lineham WM, Taylor PR, Liotta LA, Emmert-Buck MR and Petricoin III EF. (2000). Cancer Research, 60, 6293-6297.
13. Pisani P, Parkin DM and Ferlay J. (1993). Int. J. Cancer, 55, 891-903.
14. Rothhut B. (1997). Cell Mol. Life Sci., 53, 522-526.
15. Roy-Choudhury S, Mishra VS, Low MG and Das M. (1988). Proc. Natl. Acad. Sci. USA, 85, 2014-2018.
16. Schlaepfer DD and Haigler HT. (1990). J. Cell Biol., 111, 229-238.
17. Solito E, de Coupade C, Parente L, Flower RJ and Russo-Marie F. (1998). Cell Growth Differ., 9, 327-336.
18. Tait JF, Sakata M, McMullen BA, Miao CH, Funakoshi T, Hendrickson LE and Fujikawa K. (1988). Biochemistry, 27, 6268-6276.
19. Violette SM, King I, Browning JL, Pepinsky RB, Wallner BP and Sartorelli AC. (1990). J. Cell Physiol., 142, 70-77.
20. Vishwanath BS, Frey FJ, Bradbury M, Dallman MF and Frey BM. (1992). Endocrinol., 130, 585-591.
21. Wu YL, Jiang XR, Lillington DM, Newland AC and Kelsey SM. (2000). Br. J. Haematol., 111, 807-816.